Get started
Author

Laura Farrelly

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
2015 · Amit M Oza, Adrian D Cook, et al. · The Lancet Oncology · 875
PDF
Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial
2004 · C Chintu, GJ Bhat, et al. · The Lancet · 387
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma
2021 · Lewis Au, Emine Hatipoglu, et al. · Cancer Cell · 261
PDF
Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial
2016 · Jonathan A Ledermann, Andrew C Embleton, et al. · The Lancet · 237
PDF
Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland
2003 · D M Gibb, T Duong, et al. · BMJ · 226
PDF
Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial
2024 · Mary McCormack, Mary McCormack, et al. · The Lancet · 185
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
2022 · Ignace Vergote, Antonio Gonzalez-Martin, et al. · The Lancet Oncology · 139
The Impact of Cardiac Radiation Dosimetry on Survival After Radiation Therapy for Non-Small Cell Lung Cancer
2017 · S. Vivekanandan, D.B. Landau, et al. · International Journal of Radiation Oncology*Biology*Physics · 115
PDF
Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue
2020 · Kevin Litchfield, Stacey Stanislaw, et al. · Cell Reports · 76
PDF
Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001
2021 · Christian Marth, Rafal Tarnawski, et al. · International Journal of Gynecological Cancer · 71
PDF
Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort study
2025 · Amyn Bhamani, Andrew Creamer, et al. · The Lancet Oncology · 65
LBA8 A randomised phase III trial of induction chemotherapy followed by chemoradiation compared with chemoradiation alone in locally advanced cervical cancer: The GCIG INTERLACE trial
2023 · M. McCormack, D. Gallardo Rincón, et al. · Annals of Oncology · 65
PDF
Plasma Pharmacokinetics of Once- versus Twice-Daily Lamivudine and Abacavir: Simplification of Combination Treatment in HIV-1-Infected Children (Penta-13)
2005 · Alina Bergshoeff, David Burger, et al. · Antiviral Therapy · 48
PDF
Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort study
2023 · Jennifer L Dickson, Helen Hall, et al. · The Lancet Public Health · 46
PDF
Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer
2025 · Rebecca Kristeleit, Michael-John Devlin, et al. · JAMA Oncology · 41
PDF
Detection of COPD in the SUMMIT Study lung cancer screening cohort using symptoms and spirometry
2022 · Sophie Tisi, Jennifer L. Dickson, et al. · European Respiratory Journal · 34
PDF
Adherence and Acceptability of Once Daily Lamivudine and Abacavir in Human Immunodeficiency Virus Type-1 Infected Children
2006 · Marthe LePrevost, Hannah Green, et al. · The Pediatric Infectious Disease Journal · 34
ICON 9—an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy
2020 · Osnat Elyashiv, Jonathan Ledermann, et al. · International Journal of Gynecological Cancer · 32
521MO Efficacy of pembrolizumab monotherapy (PM) for advanced clear cell gynaecological cancer (CCGC): Phase II PEACOCC trial
2022 · R. Kristeleit, A.R. Clamp, et al. · Annals of Oncology · 31
Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3–<36 months
2009 · Paediatric European Network for Treatment of AIDS (PENTA), Evelyne Jacqz-Aigrain, et al. · Antiviral Therapy · 29
PDF
Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial
2021 · J.A. Ledermann, A.C. Embleton-Thirsk, et al. · ESMO Open · 28
PDF
Utilisation of primary care electronic patient records for identification and targeted invitation of individuals to a lung cancer screening programme
2022 · Jennifer L. Dickson, Helen Hall, et al. · Lung Cancer · 18
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay
2022 · Francesco Orlando, Alessandro Romanel, et al. · NAR Cancer · 18
PDF
Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer
2019 · John D. Fenwick, David B. Landau, et al. · International Journal of Radiation Oncology*Biology*Physics · 18
PDF
Ganetespib in Combination with Pemetrexed–Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib Trial
2020 · Dean A. Fennell, Sarah Danson, et al. · Clinical Cancer Research · 17
Works count: 115
Citation count: 3,064
H-index: 19
I10-index: 31
Year
Topic
Type